“ Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers ” (2015) Brazilian Journal of Pharmaceutical Sciences, 51(1), pp. 203–211. doi:10.1590/S1984-82502015000100020.